N-power Medicine

This study aims to create better comparison groups for future lung cancer research by tracking patients who are already receiving standard chemotherapy. It will follow 550 adults with advanced lung cancer that has spread, collecting data on how they respond to their current treat…

This study aims to gather detailed, real-world information on how well the drug osimertinib works for people with advanced lung cancer that has a specific genetic change (EGFR mutation). It will follow about 130 patients who are starting this treatment, collecting data on their h…

This study is creating a large registry to collect information on how cancer is treated in real-world clinics and what the outcomes are. It will follow 20,000 adult cancer patients at participating centers, gathering data on their treatments, side effects, and results through med…